regulation of type II interferon-mediated signaling pathway / HSP90-CDC37 chaperone complex / positive regulation of mitophagy in response to mitochondrial depolarization / protein kinase regulator activity / protein folding chaperone complex / sperm mitochondrial sheath / dATP binding / Scavenging by Class F Receptors / sulfonylurea receptor binding / CTP binding ...regulation of type II interferon-mediated signaling pathway / HSP90-CDC37 chaperone complex / positive regulation of mitophagy in response to mitochondrial depolarization / protein kinase regulator activity / protein folding chaperone complex / sperm mitochondrial sheath / dATP binding / Scavenging by Class F Receptors / sulfonylurea receptor binding / CTP binding / positive regulation of protein polymerization / vRNP Assembly / UTP binding / sperm plasma membrane / positive regulation of tau-protein kinase activity / post-transcriptional regulation of gene expression / chaperone-mediated autophagy / telomerase holoenzyme complex assembly / protein insertion into mitochondrial outer membrane / regulation of cyclin-dependent protein serine/threonine kinase activity / Respiratory syncytial virus genome replication / Rho GDP-dissociation inhibitor binding / Uptake and function of diphtheria toxin / mitochondrial transport / Drug-mediated inhibition of ERBB2 signaling / Resistance of ERBB2 KD mutants to trastuzumab / Resistance of ERBB2 KD mutants to sapitinib / Resistance of ERBB2 KD mutants to tesevatinib / Resistance of ERBB2 KD mutants to neratinib / Resistance of ERBB2 KD mutants to osimertinib / Resistance of ERBB2 KD mutants to afatinib / Resistance of ERBB2 KD mutants to AEE788 / Resistance of ERBB2 KD mutants to lapatinib / Drug resistance in ERBB2 TMD/JMD mutants / PIWI-interacting RNA (piRNA) biogenesis / TPR domain binding / non-chaperonin molecular chaperone ATPase / Assembly and release of respiratory syncytial virus (RSV) virions / regulation of postsynaptic membrane neurotransmitter receptor levels / dendritic growth cone / regulation of type I interferon-mediated signaling pathway / Sema3A PAK dependent Axon repulsion / regulation of protein ubiquitination / skeletal muscle contraction / HSF1-dependent transactivation / positive regulation of cell size / response to unfolded protein / telomere maintenance via telomerase / chaperone-mediated protein complex assembly / protein unfolding / HSF1 activation / regulation of protein-containing complex assembly / Attenuation phase / protein targeting / RHOBTB2 GTPase cycle / eNOS activation / axonal growth cone / positive regulation of lamellipodium assembly / DNA polymerase binding / Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation / Loss of Nlp from mitotic centrosomes / Loss of proteins required for interphase microtubule organization from the centrosome / Recruitment of mitotic centrosome proteins and complexes / : / Signaling by ERBB2 / cardiac muscle cell apoptotic process / positive regulation of defense response to virus by host / endocytic vesicle lumen / positive regulation of cardiac muscle contraction / Recruitment of NuMA to mitotic centrosomes / response to salt stress / Anchoring of the basal body to the plasma membrane / heat shock protein binding / HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand / activation of innate immune response / nitric-oxide synthase regulator activity / positive regulation of interferon-beta production / response to cold / Constitutive Signaling by Overexpressed ERBB2 / AURKA Activation by TPX2 / lysosomal lumen / ESR-mediated signaling / protein tyrosine kinase binding / VEGFR2 mediated vascular permeability / response to cocaine / brush border membrane / ATP-dependent protein folding chaperone / Signaling by ERBB2 TMD/JMD mutants / neuron migration / Hsp90 protein binding / Constitutive Signaling by EGFRvIII / DDX58/IFIH1-mediated induction of interferon-alpha/beta / Signaling by ERBB2 ECD mutants / tau protein binding / Signaling by ERBB2 KD Mutants / Regulation of necroptotic cell death / Regulation of actin dynamics for phagocytic cup formation / cellular response to virus / Downregulation of ERBB2 signaling / kinase binding 類似検索 - 分子機能
THIS RESIDUE IS UNP DATABASE P07900 REF.1(CAA33259)
-
実験情報
-
実験
実験
手法: 溶液NMR 詳細: Structure of the human CDC37-HSP90 complex based on NMR using CSPs, RDCs and docking with HADDOCK
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
タイプ
1
1
1
2D 1H-15N HSQC
1
2
2
3D 1H-15N NOESY
1
3
3
3D 1H-15N NOESY
1
4
1
IPAP(1H,15N)HSQC
1
5
1
IPAP(1H,15N)HSQC
-
試料調製
詳細
Solution-ID
内容
溶媒系
1
0.8mM [U-100% 15N] human HSP90, 0.8mM [U-100% 15N] human CDC37, 50mM HEPES, 100mM sodium chloride, 1mM DTT, 90% H2O/10% D2O
90% H2O/10% D2O
2
0.8mM [U-100% 15N, U-100% 2H] human HSP90, 0.8mM human CDC37, 50mM HEPES, 100mM sodium chloride, 1mM DTT, 90% H2O/10% D2O
90% H2O/10% D2O
3
0.8mM human HSP90, 0.8mM [U-100% 15N, U-100% 2H] human CDC37, 50mM HEPES, 100mM sodium chloride, 1mM DTT, 90% H2O/10% D2O
90% H2O/10% D2O
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
0.8mM
humanHSP90
[U-100% 15N]
1
0.8mM
humanCDC37
[U-100% 15N]
1
50mM
HEPES
1
100mM
sodiumchloride
1
1mM
DTT
1
0.8mM
humanHSP90
[U-100% 15N, U-100% 2H]
2
0.8mM
humanCDC37
2
50mM
HEPES
2
100mM
sodiumchloride
2
1mM
DTT
2
0.8mM
humanHSP90
3
0.8mM
humanCDC37
[U-100% 15N, U-100% 2H]
3
50mM
HEPES
3
100mM
sodiumchloride
3
1mM
DTT
3
試料状態
イオン強度: 100 / pH: 7.4 / 圧: ambient / 温度: 298 K
-
NMR測定
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker Avance
Bruker
AVANCE
900
1
Bruker Avance
Bruker
AVANCE
800
2
Bruker Avance
Bruker
AVANCE
700
3
-
解析
NMR software
名称
バージョン
開発者
分類
TopSpin
2.1
BrukerBiospin
collection
TopSpin
2.1
BrukerBiospin
解析
Sparky
3.113
Goddard
データ解析
Sparky
3.113
Goddard
peakpicking
CARA
1.8.3
KellerandWuthrich
データ解析
CARA
1.8.3
KellerandWuthrich
peakpicking
CNS
1.1
Brunger, Adams, Clore, Gros, NilgesandRead
構造決定
CNS
1.1
Brunger, Adams, Clore, Gros, NilgesandRead
精密化
HADDOCK
2
A. Bonvin & C. Dominguez
geometryoptimization
HADDOCK
2
Dominguez, BoelensandBonvin
精密化
HADDOCK
2
A. Bonvin & C. Dominguez
構造決定
精密化
手法: simulated annealing, torsion angle dynamics / ソフトェア番号: 1 詳細: The structure was calculated using HADDOCK Details can be found in the jrnl citation above
代表構造
選択基準: best haddock score
NMRアンサンブル
コンフォーマー選択の基準: structures with the best HADDOCK scoring 計算したコンフォーマーの数: 200 / 登録したコンフォーマーの数: 10 / 代表コンフォーマー: 1